Navigation path

Community Register of medicinal products

Community register of orphan medicinal products


GRANTED  

Product information

Allogeneic ex vivo expanded umbilical cord blood cells

EU orphan designation number: EU/3/09/665   
Active ingredient: Allogeneic ex vivo expanded umbilical cord blood cells
Indication: Treatment of chronic myeloid leukaemia
Sponsor: Teva Pharma GmbH
Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2009 Centralised Orphan - Designation EMEA/OD/035/09 (2009)7845 of 08/10/2009
15/09/2011 Other procedure -